Dr. Bedard successfully defended her PhD thesis, “Sex-Specific Responses to Withdrawal in Mouse Models of Opioid Use” under the guidance of Dr. Zoe McElligott on July 19!
Publications
Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism. Bedard ML, Huang XP, Murray JG, Nowlan AC, Conley SY, Mott SE, Loyack SJ, Cline CA, Clodfelter CG, Dasgupta N, Krumm B, Roth BL, McElligott ZA. Addict Neurosci. 2024 Jun;11:100155. doi: 10.1016/j.addicn.2024.100155. Epub 2024 May 3. PMID: 39086495 <
Probing different paradigms of morphine withdrawal on sleep behavior in male and female C57BL/6J mice. Bedard ML, Lord JS, Perez PJ, Bravo IM, Teklezghi AT, Tarantino LM, Diering GH, McElligott ZA. Behav Brain Res. 2023 Jun 25;448:114441. doi: 10.1016/j.bbr.2023.114441. Epub 2023 Apr 17. PMID: 37075956
All Hands on Deck: We Need Multiple Approaches To Uncover the Neuroscience behind the Opioid Overdose Crisis. Bedard ML, Nowlan AC, Martin Del Campo Z, Miller C, Dasgupta N, McElligott ZA. ACS Chem Neurosci. 2023 Jun 7;14(11):1921-1929. doi: 10.1021/acschemneuro.2c00818. Epub 2023 May 9. PMID: 37159430
Honors, Awards, Highlights
NIH F31 Fellowship – January 18, 2023 to support her research in Opioid Withdrawal Syndrome.
UNC Pharmacological Sciences Training Program T32 – July 2020 – 2022.
Congratulations, Madigan, we wish you all the best!
More pics from Madigan’s defense. Click for larger view.
